Pharmaceutical Sales Certification (PSC)
Pharmacy Sales Rep Cert
Section 1: Industry Overview & Market Dynamics (1–20)
1. Which of the following statements most accurately reflects the social and
economic importance of the pharmaceutical industry in the United States?
A) It is a low-risk, moderate-return industry
B) It accounts for less than 10% of total U.S. healthcare spending while delivering
disproportionate clinical value
C) Prescription drugs are the primary driver of rising healthcare costs
D) The U.S. represents only 15–20% of global pharmaceutical revenues
Correct Answer: B
Rationale: Prescription and non-prescription drugs represent approximately 8–
10% of total U.S. healthcare expenditures yet are responsible for dramatic
reductions in hospitalization, surgery, and long-term care costs. The U.S. accounts
for ~45–50% of global pharmaceutical revenues .
2. In 2024–2025, which geographic region continues to represent the largest
single market for ethical pharmaceuticals?
A) European Union (27 countries combined)
B) Japan
C) United States
D) China
Correct Answer: C
,Rationale: The U.S. still captures approximately 48–50% of global pharmaceutical
sales due to higher pricing, faster adoption of new therapies, and a large insured
population .
3. What is the approximate global market revenue of the pharmaceutical
industry?
A) $350 billion
B) $650 billion
C) $950 billion
D) $1.2 trillion
Correct Answer: C
Rationale: The global pharmaceutical market is approximately $950 billion in
annual revenue .
4. Pharmaceutical sales are highest in which regions?
A) South America, Africa, and Asia
B) The U.S., Western Europe, and Japan
C) Eastern Europe, India, and China
D) Australia, Canada, and Mexico
Correct Answer: B
Rationale: The U.S., Western Europe, and Japan represent the largest
pharmaceutical markets by revenue .
5. What factors have significantly contributed to recent growth in the
pharmaceutical industry?
A) Decreased life expectancy and population decline
B) Population growth and increasing life expectancy
C) Reduced healthcare spending and generic-only prescribing
D) Decline in chronic disease prevalence
,Correct Answer: B
Rationale: Population growth and increasing life expectancy (particularly the
aging baby-boomer population) have fueled recent growth in the pharmaceutical
industry .
6. Which of the following is the single most important driver of
pharmaceutical industry revenue growth from 2015 to 2025?
A) Population growth in emerging markets
B) Increased life expectancy and the aging population in developed countries
C) Rising generic penetration
D) Expansion of over-the-counter switching
Correct Answer: B
Rationale: The aging baby-boomer population (65+ age group growing from 46
million in 2015 to over 80 million in 2025 in the U.S. alone) drives demand for
chronic therapies in oncology, cardiology, neurology, rheumatology, and diabetes .
7. By 2025, which therapeutic category has overtaken all others to become the
#1 driver of U.S. pharmaceutical spending?
A) Antidiabetic agents
B) Oncology
C) Autoimmune / Immunology
D) Cardiovascular
Correct Answer: B
Rationale: Oncology overtook immunology in 2023 and continues to dominate in
2025, with spending at >$95 billion annually in the U.S. driven by checkpoint
inhibitors, CAR-Ts, ADCs, and targeted oral oncolytics .
8. The single largest contributor to oncology spending growth from 2022–2025
is:
, A) PD-1/PD-L1 inhibitors (Keytruda, Opdivo)
B) PARP inhibitors
C) CDK 4/6 inhibitors
D) Antibody-drug conjugates
Correct Answer: A
Rationale: Pembrolizumab (Keytruda) alone exceeded $25 billion in global sales
in 2024 and is on pace for $28+ billion in 2025, making the PD-1/PD-L1 class the
largest in pharmaceutical history .
9. What is the focus of the biotechnology industry in medicine?
A) Traditional chemical synthesis
B) Herbal and natural product extraction
C) Gene research, genetically-altered drugs, and molecular biology
D) Over-the-counter medication development
Correct Answer: C
Rationale: The biotechnology industry focuses on gene research, genetically-
altered drugs, and molecular biology .
10. The U.S. accounts for approximately what percentage of the world's
pharmaceutical revenues?
A) 25%
B) 35%
C) 50%
D) 75%
Correct Answer: C
Rationale: The United States accounts for about 50% of the world's
pharmaceutical revenues .
Pharmacy Sales Rep Cert
Section 1: Industry Overview & Market Dynamics (1–20)
1. Which of the following statements most accurately reflects the social and
economic importance of the pharmaceutical industry in the United States?
A) It is a low-risk, moderate-return industry
B) It accounts for less than 10% of total U.S. healthcare spending while delivering
disproportionate clinical value
C) Prescription drugs are the primary driver of rising healthcare costs
D) The U.S. represents only 15–20% of global pharmaceutical revenues
Correct Answer: B
Rationale: Prescription and non-prescription drugs represent approximately 8–
10% of total U.S. healthcare expenditures yet are responsible for dramatic
reductions in hospitalization, surgery, and long-term care costs. The U.S. accounts
for ~45–50% of global pharmaceutical revenues .
2. In 2024–2025, which geographic region continues to represent the largest
single market for ethical pharmaceuticals?
A) European Union (27 countries combined)
B) Japan
C) United States
D) China
Correct Answer: C
,Rationale: The U.S. still captures approximately 48–50% of global pharmaceutical
sales due to higher pricing, faster adoption of new therapies, and a large insured
population .
3. What is the approximate global market revenue of the pharmaceutical
industry?
A) $350 billion
B) $650 billion
C) $950 billion
D) $1.2 trillion
Correct Answer: C
Rationale: The global pharmaceutical market is approximately $950 billion in
annual revenue .
4. Pharmaceutical sales are highest in which regions?
A) South America, Africa, and Asia
B) The U.S., Western Europe, and Japan
C) Eastern Europe, India, and China
D) Australia, Canada, and Mexico
Correct Answer: B
Rationale: The U.S., Western Europe, and Japan represent the largest
pharmaceutical markets by revenue .
5. What factors have significantly contributed to recent growth in the
pharmaceutical industry?
A) Decreased life expectancy and population decline
B) Population growth and increasing life expectancy
C) Reduced healthcare spending and generic-only prescribing
D) Decline in chronic disease prevalence
,Correct Answer: B
Rationale: Population growth and increasing life expectancy (particularly the
aging baby-boomer population) have fueled recent growth in the pharmaceutical
industry .
6. Which of the following is the single most important driver of
pharmaceutical industry revenue growth from 2015 to 2025?
A) Population growth in emerging markets
B) Increased life expectancy and the aging population in developed countries
C) Rising generic penetration
D) Expansion of over-the-counter switching
Correct Answer: B
Rationale: The aging baby-boomer population (65+ age group growing from 46
million in 2015 to over 80 million in 2025 in the U.S. alone) drives demand for
chronic therapies in oncology, cardiology, neurology, rheumatology, and diabetes .
7. By 2025, which therapeutic category has overtaken all others to become the
#1 driver of U.S. pharmaceutical spending?
A) Antidiabetic agents
B) Oncology
C) Autoimmune / Immunology
D) Cardiovascular
Correct Answer: B
Rationale: Oncology overtook immunology in 2023 and continues to dominate in
2025, with spending at >$95 billion annually in the U.S. driven by checkpoint
inhibitors, CAR-Ts, ADCs, and targeted oral oncolytics .
8. The single largest contributor to oncology spending growth from 2022–2025
is:
, A) PD-1/PD-L1 inhibitors (Keytruda, Opdivo)
B) PARP inhibitors
C) CDK 4/6 inhibitors
D) Antibody-drug conjugates
Correct Answer: A
Rationale: Pembrolizumab (Keytruda) alone exceeded $25 billion in global sales
in 2024 and is on pace for $28+ billion in 2025, making the PD-1/PD-L1 class the
largest in pharmaceutical history .
9. What is the focus of the biotechnology industry in medicine?
A) Traditional chemical synthesis
B) Herbal and natural product extraction
C) Gene research, genetically-altered drugs, and molecular biology
D) Over-the-counter medication development
Correct Answer: C
Rationale: The biotechnology industry focuses on gene research, genetically-
altered drugs, and molecular biology .
10. The U.S. accounts for approximately what percentage of the world's
pharmaceutical revenues?
A) 25%
B) 35%
C) 50%
D) 75%
Correct Answer: C
Rationale: The United States accounts for about 50% of the world's
pharmaceutical revenues .
